THERAPY DOSSIER · th-487be821b96f

Compound Cotinus coggygria oral liquid

Nutraceutical

Evidence & regulatory context

Mechanism: Not recorded
Target: Not recorded
Injury models: Chemical/toxin
Reported indication: Not recorded
First approval: Not recorded
Development stage: Not recorded
ChEMBL record: Not recorded
ChEMBL max phase: Not recorded
Synonyms: Not recorded
Note: Not recorded

Clinical trials 1

0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.

NCT07254819 ↗NAcompleted

The Effect of Cotinus Coggygria Mouthwash on Halitosis and Oral Hygiene in Orthodontic Patients: a Randomized Clinical Trial

Orthodontic Appliance Complication · Halitosis

Enrolment: 30 · Results not recorded

Preclinical evidence 1

1 studies reported at therapy level; 1 evidence entries itemised.

PMID 31308036 ↗2019Reported benefit

Protective Effect of Compound Cotinus coggygria Oral Liquid on Mice Acute Liver Injury Induced by D-Galactosamine.

MouseChemical/toxinn = 72 mice randomly divided into 6 groupsOralLarge 30 ml/kg, medium 15 ml/kg and small 7.5 ml/kg; positi…

Model: Acute liver injury induced by D-galactosamine

D-galactosamine raised serum and hepatic alanine and aspartate aminotransferase and caused marked hepatocyte necrosis. All doses of compound Cotinus coggygria oral liquid significantly lowered serum transaminases, while the large and medium doses also reduced the liver index and hepatic transaminas…

Extraction: extract · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.

Loading the evidence…